Skip to main content

Aermony Respiclick™

This product is manufactured by Teva Pharmaceutical Industries using the ingredient fluticasone propionate.

This product is taken via oral inhalation.

Why is it prescribed?

Fluticasone is used to control the signs and symptoms of asthma that are responsive to orally inhaled corticosteroids. It is also used as a nasal spray to relieve nasal congestion in the treatment of seasonal and perennial rhinitis (runny nose) where inflammation of the lining of the nose causes it to run.

  • The Aermony Respiclick inhaler does not require priming.
  • There is no button or canister that you need to press to load a dose. Opening the green cap loads the dose. Every time the green cap is opened and it “clicks”, one dose is ready to be inhaled. If you do not hear the “click” sound the inhaler may not be activated to give you a dose of medicine.
  • Always close the green cap after using it so your inhaler will be ready for you to take your next dose.
  • Do not open the cap unless you are ready to take your next dose. Opening and closing the cap without inhaling a dose will waste the medicine and may damage your inhaler.
  • Your Aermony Respiclick inhaler contains dry powder so it is important that you do not blow or breathe into it.
  • The Aermony Respiclick inhaler contains 60 actuations (inhalations).
  • There is a counter in the back of the inhaler with a viewing window that shows you how much of the medicine you have left.
  • The counter will count down (in units of two) each time the green cap is opened and closed (for example, 60, 58, 56, etc.).
  • When there are 20 actuations left, the colour of the numbers will change to red. You should refill your prescription or ask your doctor for another prescription.
  • When the counter shows the number ‘0’ the background will change to red and the colour of the number ‘0’ will change to black. Your inhaler is empty and you should stop using the inhaler and throw it away. .
  • Open the green cap all the way back until you feel and hear a “click.
  • Every time the green cap is opened and it clicks, one dose is ready to be inhaled.
  • Do not open the green cap unless you are taking a dose.
  • Make sure the cap is closed.
  • Hold the inhaler upright
  • Before inhaling, hold the inhaler away from your mouth and breathe out through your mouth as much air as you can and as is comfortable. Never breathe out into the inhaler mouthpiec
  • Place the mouthpiece in your mouth and close your lips around it so you form a good seal.
  • Breathe in quickly and deeply through your mouth, until your lungs feel completely full of ai

Cleaning your inhaler:

  • Never wash or put any part of the inhaler in water.
  • Gently wipe the mouthpiece with a dry cloth or tissue once a week.


Other products that have the same ingredient as Aermony Respiclick™ are •Advair® Diskus® •Advair® MDI •Apo-Fluticasone Nasal Spray •Dymista® •Flonase® nasal spray •Flovent® Diskus®  •Flovent® HFA •PMS-Fluticasone HFA •PMS-Fluticasone Propionate/ Salmeterol DPI •Teva-Fluticasone Nasal Spray •Wixela® Inhub® •

See other products used in the treatment of •allergic rhinitis •asthma •nasal polyps •perennial rhinitis •rhinitis •runny nose •seasonal allergies •seasonal rhinitis •

Usual Dose (Adults and Adolescents 12 years of age and older):
Use 1 inhalation twice a day, about 12 hours apart.

Fluticasone is a highly potent corticosteroid that possesses strong anti- inflammatory activity. Whether inhaled through the nose or into the lungs, the effect of the drug is local (acting directly on the tissue it comes in contact with). The amount absorbed by the body is minimal and therefore the incidence of unwanted effects is low.

Along with its needed effects, fluticasone may cause some unwanted or undesirable effects. Often, fluticasone users who use their medication properly, never experience any unwanted effects. The severity and duration of these effects are dependant on many factors including duration of therapy, dose, route of administration and individual response. Possible unwanted effects include:

  • sneezing immediately after use (nasal spray only)
  • irritation and burning in the nose (nasal spray only)
  • localized infection of Candida Albicans (yeast) of the mouth and throat

Less common:

  • sore throat (oral inhalation only)
  • hoarseness (oral inhalation only)
  • cough
  • headache
  • nausea


  • immediate or delayed allergic reaction (e.g. rash, hives, and bronchospasm)
  • flushing, itchiness, and swelling of the eyes, face, lips and throat


Use as directed. Never use a higher dose than what you have been prescribed. Using higher than recommended doses will cause greater absorption by the body and possibly lead to greater occurrence of unwanted effects. Optimal relief of symptoms may require a few days of continuous therapy.
If symptoms do not improve or the condition worsens, the doctor should be contacted.
Treatment with fluticasone should never be stopped without first consulting your doctor.
Discontinuation of fluticasone requires gradual tapering or you may experience a flare-up of your condition.
Inadequate response can often be a result of improper use of the delivery device. Your doctor or pharmacist should instruct you on the correct use of these preparations. Each product comes with a package insert that should be read and then kept as a reference.
Children using any of these preparations should do so under the direct supervision of an adult who is familiar with it's proper use.
It is important to inform subsequent physicians that you are using or have used fluticasone or any other corticosteroids as this may vary the treatment plan.
When you have been treated with oral corticosteroids (e.g. prednisone) for prolonged periods and are being transferred to intranasally or orally inhaled fluticasone, you may experience withdrawal symptoms (e.g. joint and/or muscular pain and depression). These symptoms should be reported to your doctor, especially if you have associated asthma or another condition in which too rapid a decrease in systemic steroids may cause a severe flare-up of symptoms. Fluticasone may mask some signs of infection and new infections may appear. The body tends to have a decreased resistance to localized infections while on this therapy so anything of this nature should be reported to the doctor. Drug Interactions: Due to very low absorption at therapeutic doses, it is unlikely that there would be any important interactions. However, it is important to tell your doctor and pharmacist of any prescription or over-the-counter medications you are taking. However in people with hypoprothrombinemia (deficiency of a clotting factor in the blood resulting in an increased tendency to bleed) ASA (e.g. Aspirin®) should be used cautiously used in combination with corticosteroids. Ritonavir (e.g. Norvir®) has been known to interact with fluticasone propionate.
Use is not recommended in the following situations:

  • allergy to fluticasone propionate or any component of the preparation.
  • tuberculosis
  • untreated fungal, bacterial and viral infections

Caution recommended in the following situations:

  • people previously treated for prolonged periods with oral corticosteroids (e.g. prednisone)

Use in pregnancy: If you suspect that you might be pregnant, consult your doctor. Use while breastfeeding: It is not known whether fluticasone propionate is passed into breast milk, but it is suspected. Consult your doctor or pharmacist before use.